Drug development and industrial pharmacy · 2026
Stability, in vitro release, and pharmacokinetic evaluation of standardized crude extracts, isolated compounds, and their nano-liposomes derived from Syzygium campanulatum Korth using Sprague-Dawley rats.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hakeem Memon Abdul, Memon Osama, Rahman Asad Ur, Khan Muhammad, Lashari Hosh Muhammad, Suheryani Imran, Esa Muhammad, Khalil Atif Ali Khan, Jahan Saqib
Аннотация
OBJECTIVE: This study aimed to leverage nano-liposomes (NLs) for optimizing the solubility, bioavailability, and pharmacokinetic profiles of 7-hydroxy-5-methoxy-6,8-dimethyl flavanone (7-HMDF), 5,7-dihydroxy-6,8-dimethyl-flavanone (HMF), 2,4-dihydroxy-6-methoxy- 3,5-dimethylchalcone (DMC), betulinic acid (BA), and ursolic acid (UA) derived from the standardized ethanol extract (EE) and supercritical fluid extract (SFE) of Syzygium campanulatum Korth leaves.
SIGNIFICANCE: This study provides a comprehensive/validated approach for the nano-pharmaceutical development of poorly bioavailable phytomedicines.
METHODS: NLs encapsulating BA, DMC, EE, and SFE were prepared (thin-film hydration method), optimized, and subsequently characterized. Besides, 6-months stability test, NL-EE and NL-SFE also underwent oral pharmacokinetic evaluation using Sprague-Dawley (SD) rats.
RESULTS: HPLC analysis revealed higher concentration of marker compounds within SFE as compared to EE and in silico ADME-Tox profiling predicted safe and favourable pharmacokinetics of those marker compounds. Additionally, NLs demonstrated optimum size (70 238nm), polydispersity index (0.250.43), zeta potential (-28 to -49 mV), encapsulation efficiency (4065%), in vitro drug release, and six months stability. Shelf-life was temperature-dependent, with BA stable at 25°C and DMC moderately stable, but both declined sharply at 60 °C. NLs encapsulation noticeably increased the aqueous solubility of the marker compounds by 50%. Finally, in vivo pharmacokinetic evaluation confirmed the presence of 7-HMDF, HMF, and DMC in rats' plasma, indicating improved absorption, prolonged circulation, enhanced bioavailability, and sustained release of NLs as compared to their non-liposomal counterparts (EE/SFE).
CONCLUSIONS: NL encapsulation significantly enhanced the solubility, entrapment efficiency, oral bioavailability, and pharmacokinetic profiles of 7-HMDF, HMF, and DMC from S. campanulatum extracts, demonstrating NLs as promising drug delivery systems.
SIGNIFICANCE: This study provides a comprehensive/validated approach for the nano-pharmaceutical development of poorly bioavailable phytomedicines.
METHODS: NLs encapsulating BA, DMC, EE, and SFE were prepared (thin-film hydration method), optimized, and subsequently characterized. Besides, 6-months stability test, NL-EE and NL-SFE also underwent oral pharmacokinetic evaluation using Sprague-Dawley (SD) rats.
RESULTS: HPLC analysis revealed higher concentration of marker compounds within SFE as compared to EE and in silico ADME-Tox profiling predicted safe and favourable pharmacokinetics of those marker compounds. Additionally, NLs demonstrated optimum size (70 238nm), polydispersity index (0.250.43), zeta potential (-28 to -49 mV), encapsulation efficiency (4065%), in vitro drug release, and six months stability. Shelf-life was temperature-dependent, with BA stable at 25°C and DMC moderately stable, but both declined sharply at 60 °C. NLs encapsulation noticeably increased the aqueous solubility of the marker compounds by 50%. Finally, in vivo pharmacokinetic evaluation confirmed the presence of 7-HMDF, HMF, and DMC in rats' plasma, indicating improved absorption, prolonged circulation, enhanced bioavailability, and sustained release of NLs as compared to their non-liposomal counterparts (EE/SFE).
CONCLUSIONS: NL encapsulation significantly enhanced the solubility, entrapment efficiency, oral bioavailability, and pharmacokinetic profiles of 7-HMDF, HMF, and DMC from S. campanulatum extracts, demonstrating NLs as promising drug delivery systems.